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Research
Ozone (O3) is the most toxic oxidant gas in 
air pollution mixtures and has been associ-
ated with numerous health effects, includ-
ing airway inflammation and hyperreactivity 
(Plopper et al. 1998; Toward and Broadley 
2002), exacerbation of asthma (McConnell 
et al. 2002; Neuhaus-Steinmetz et al. 2000), 
and increased mortality and morbidity (Jerrett 
et al. 2009). O3-induced lung inflammation is 
characterized by polymorphonuclear leukocyte 
(PMN) infiltration (Mudway and Kelly 2000) 
and release of a number of proinflammatory 
cytokines, such as tumor necrosis factor-α 
(TNF-α) (Bhalla et al. 2002; Cho et al. 2001), 
interleukin-6 (IL-6) (Johnston et al. 2005), 
and the PMN chemoattractant macrophage 
inflammatory protein 2 (MIP-2) (Driscoll 
et al. 1993). O3 causes upregulation of induc-
ible nitric oxide synthase (iNOS), which fur-
ther contributes to lung injury (Fakhrzadeh 
et al. 2002; Inoue et al. 2000; Kleeberger et al. 
2001). Lung injury after O3 exposure may 
directly or indirectly affect adaptive immune 
responses such as T-cell proliferation (Jakab 
et al. 1995), response to allergen (Depuydt 
et al. 2002), and upregulation of costimula-
tory molecules such as cellular differentiation 
factor 86 (CD86, B7.2) that contribute to 
T-cell activation (Koike et al. 2001).
Interleuken (IL)-10 is a pleiotro-
pic cytokine that is produced by activated 
monocytes, macrophages, and helper T-cells, 
and B-cells. IL-10 reduces TNF-α and IL-6 
production (Lang et al. 2002), and inhibits 
MIP-2 (Standiford et al. 1995). Previously, 
Reinhart et al. (1999) showed that intratra-
cheal instillation of recombinant IL-10 in 
Sprague-Dawley rats before O3 exposure 
significantly reduced O3-induced PMN 
infiltration and pulmonary hyperpermeabil-
ity responses [fibronectin, albumin, bron-
choalveolar lavage fluid (BALF) protein]. 
However, the relationship between IL-10 
and other inflammatory mediators and 
downstream molecular events has not been 
investigated. IL-10 inhibits inflammation by 
suppressing macrophage CD86 expression 
leading to anergic T-cells in a schistosomiasis 
model (Ding et al. 1993; Flores Villanueva 
et al. 1994). IL-10 also inhibits iNOS pro-
duction in macrophages (Cunha et al. 1992) 
and blocks nuclear factor-κB (NF-κB) activa-
tion (Saadane et al. 2005). Tyrosine phos-
phorylation of the intracellular domains of 
the IL-10 receptor is known to activate the 
signaling transducer and activator of tran-
scription-3 (STAT3) pathway (Donnelly 
et al. 1999). Tarzi et al. (2006) observed that 
peptide immunotherapy caused induction of 
IL-10 and suppressor of cytokine signaling 
3 (SOCS3) in a bee venom model, and Gao 
and Ward (2007) has implicated SOCS3 in 
inflammatory diseases.
Polymorphisms in the human IL10 gene 
have been associated with the development of 
asthma (Chatterjee et al. 2005) and lipopoly-
saccharide (LPS) sensitivity (Schippers et al. 
2005). The functional role of pulmonary 
IL-10 has been studied in experimental ani-
mals in response to LPS (Standiford et al. 
1995), silica (Huaux et al. 1998), and infec-
tious organisms (Higgins et al. 2003) and as 
a key mediator in allergy (Akdis et al. 2001) 
and cystic fibrosis (Saadane et al. 2005). 
However, the role of IL-10 in O3-induced 
lung inflammation and its underlying mecha-
nism has not been sufficiently studied.
In this study, we tested the hypothesis 
that targeted deletion of Il10 in mice would 
enhance O3-induced pulmonary inflamma-
tion via modulation of expression of inflam-
matory mediators CD86 and MIP-2 and 
nuclear transcription factors NF-κB and 
STAT3. We compared O3-induced altera-
tions in pulmonary injury phenotypes and 
putative downstream molecular events 
between Il10-sufficient (Il10+/+) and Il10-
deficient (Il10–/–) mice. We also used global 
mRNA expression analyses of lung tissue to 
identify patterns of gene expression that are 
modulated by IL-10 after exposure to O3. 
Enhanced O3-induced inflammation pheno-
types in Il10–/– mice compared with Il10+/+ 
mice were consistent with a protective role 
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Ba c k g r o u n d: The mechanisms underlying ozone (O3)-induced pulmonary inflammation remain 
unclear. Interleukin-10 (IL-10) is an anti-inflammatory cytokine that is known to inhibit inflamma-
tory mediators.
oBjectives: We investigated the molecular mechanisms underlying interleuken-10 (IL-10)–mediated 
attenuation of O3-induced pulmonary inflammation in mice.
Me t h o d s : Il10-deficient (Il10–/–) and wild-type (Il10+/+) mice were exposed to 0.3 ppm O3 or 
  filtered air for 24, 48, or 72 hr. Immediately after exposure, differential cell counts and total protein 
(a marker of lung permeability) were assessed from bronchoalveolar lavage fluid (BALF). mRNA 
and protein levels of cellular mediators were determined from lung homogenates. We also used 
global mRNA expression analyses of lung tissue with Ingenuity Pathway Analysis to identify pat-
terns of gene expression through which IL-10 modifies O3-induced inflammation.
re s u l t s: Mean numbers of BALF polymorphonuclear leukocytes (PMNs) were significantly greater 
in Il10–/– mice than in Il10+/+ mice after exposure to O3 at all time points tested. O3-enhanced 
nuclear NF-κB translocation was elevated in the lungs of Il10–/– compared with Il10+/+ mice. Gene 
expression analyses revealed several IL-10–dependent and O3-dependent mediators, including 
macro  phage inflammatory protein 2, cathepsin E, and serum amyloid A3.
co n c l u s i o n s: Results indicate that IL-10 protects against O3-induced pulmonary neutrophilic 
inflammation and cell proliferation. Moreover, gene expression analyses identified three response path-
ways and several genetic targets through which IL-10 may modulate the innate and adaptive immune 
response. These novel mechanisms of protection against the pathogenesis of O3-induced pulmonary 
inflammation may also provide potential therapeutic targets to protect susceptible individuals.
key w o r d s : air pollution, gene array, IL-10, inflammation, lung, ozone, pulmonary. Environ 
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for IL-10. Microarray and pathway analyses 
identified significant differences in inflam-
matory mediator expression between Il10+/+ 
and Il10–/– mice in response to O3 and sug-
gested novel genetic targets [e.g., cathepsin 
E (Ctse) and serum amyloid A3 (Saa3)] affil-
iated with Il10 expression and response to 
environmental oxidant exposure.
Materials and Methods
Animals. We purchased male Il10+/+ 
(C57BL/6) and Il10–/– (B6.129P2-Il10tm1Cgn/J) 
mice (6–8 weeks) from Jackson Laboratories 
(Bar Harbor, ME). We provided mice with 
water and pelleted open-formula rodent diet 
NIH-31 (Zeigler Brothers, Gardners, PA) ad 
libitum. All experimental procedures were 
conducted in accordance with approved guide-
lines from the National Institutes of Health 
(Institute of Laboratory Animal Resources 
1996) and the American Physiological Society 
(2002). Animals were treated humanely and 
with regard for alleviation of suffering.
O3 exposure. We placed mice in individ-
ual stainless steel wire cages within a Hazelton 
1000 chamber (Lab Products, Maywood, NJ) 
equipped with a charcoal and high-efficiency 
particulate air–filtered air supply. We exposed 
mice to 0.3 ppm O3 or filtered air for 24, 48, 
or 72 hr (23.5 hr/day) as described previously 
(Cho et al. 2007).
Necropsy and BALF analyses. We eutha-
nized mice (intraperitoneal sodium pentobar-
bital, 104 mg/kg) immediately after exposure. 
We lavaged the right lung with Hanks’ bal-
anced salt solution and processed the lung 
for cell and total protein (a marker of lung 
permeability) analyses following Cho et al. 
(2001). The left lung was snap-frozen in liq-
uid nitrogen for molecular analyses.
Histological analysis. We inflated lavaged 
right lungs with 10% formalin, removed en 
bloc, and immersed the lungs in 10% for-
malin. Details of histological analyses are in 
the Supplemental Material (doi:10.1289/
ehp.1002182). Immunohistological staining 
was done using a specific antibody against 
Ki-67 (ab15580; Abcam, Cambridge, MA); 
we followed the procedures outlined by Cho 
et al. (2007).
Real-time quantitative reverse-transcriptase 
polymerase chain reaction. We isolated total 
RNA from left lung homogenates using the 
RNeasy Midi Kit (Qiagen Inc., Valencia, CA) 
following the manufacturer’s instructions and 
as described by Cho et al. (2007). Details 
of quantitative reverse-transcriptase poly-
merase chain reaction (RT-PCR) procedures 
are outlined in the Supplemental Material 
(doi:10.1289/ehp.1002182).
Western blot analysis. We prepared total 
lung protein in RIPA buffer containing pro-
tease and phosphatase inhibitors. Details 
of Western blot procedures and analyses 
are presented in the Supplemental Material 
(doi:10.1289/ehp.1002182).
Enzyme-linked immunosorbant assay for 
MIP-2 and NF-κB subunit, p65. We used 50 
μL BALF from each mouse for enzyme-linked 
immunosorbant assay (ELISA). The proce-
dures were performed following manufactur-
er’s instructions (R&D Systems, Minneapolis, 
MN). Processing and analysis procedures 
are detailed in the Supplemental Material 
(doi:10.1289/ehp.1002182).
Nuclear protein isolation and electro-
phoretic mobility shift assay for NF-κB. We 
prepared nuclear extracts from right lung 
lobes using a Nuclear Extraction Kit (Active 
Motif, Carlsbad, CA). Details of the electro-
phoretic mobility shift assay (EMSA) pro-
cedures are in the Supplemental Material 
(doi:10.1289/ehp.1002182).
Gene array analysis. RNA isolation and 
Affymetrix GeneChip hybridization. We iso-
lated total RNA from left lung lobes, and the 
RNA was used after passing quality testing 
using an Agilent Bioanalyzer 2100 (Agilent 
Technologies, Inc., Santa Clara, CA, USA). 
For each treatment group, we performed 
GeneChip analysis (Affymetrix, Santa Clara, 
CA) analyses in duplicate (air controls) or 
triplicate (O3 exposed). Further details of 
RNA processing and hybridization are in 
the Supplemental Material (doi:10.1289/
ehp.1002182).
Data analysis. We normalized and sum-
marized the resulting files (in CEL format) 
with the Robust Multichip Average method 
using RMAExpress (http://rmaexpress.bmbol-
stad.com/). We exported log2 values for anal-
ysis using the Spotfire DecisionSite (TIBCO 
Spotfire, Somerville, MA). Hierarchical clus-
tering identified one outlier, a sample from an 
Il10–/– mouse exposed to O3 for 24 hr, which 
was not included in subsequent analysis. We 
also applied Ingenuity Pathway Analysis (IPA) 
software (Ingenuity Systems, Inc., Redwood 
City, CA), a structured network knowledge-
based approach, to evaluate functions and to 
elect putative interaction and signaling mech-
anisms through which IL-10 plays a role in 
pulmonary pathogenesis in response to O3. 
We further analyzed statistically the CEL files 
by two-way analysis of variance (ANOVA; 
p < 0.01) using genotype (Il10+/+, Il10–/–) 
and exposure (air, 24-hr O3, 48-hr O3, 72-hr 
O3) as the variables in GeneSpring GX 11.0 
Expression Analysis software program (Agilent 
Technologies). We deposited the raw data 
Figure 1. Changes in number of PMNs (A) and total protein concentration (B) recovered in BALF from 
Il10+/+ and Il10–/– mice in response to air or 0.3 ppm O3 (means ± SE; n = 8/group). *p < 0.05, air versus 
0.3 ppm O3; **p < 0.05, Il10+/+ versus Il10–/–. (C) H&E staining of 5-μm lung sections from Il10+/+ and Il10–/– 
mice after air or 0.3 ppm O3 (72 hr). Arrows illustrate areas of greatest neutrophilic inflammation, par-
ticularly around terminal bronchioles (TB) and blood vessels (V). Sections are representative of mice from 
each treatment group. (D) Ki67 immunostaining of 5-μm lung sections from Il10+/+ and Il10–/– mice after air 
or 0.3 ppm O3 (72 hr). Arrows indicate foci of cellular proliferation (arrows indicate the arrowheads shown 
in the inset). Sections are representative of mice from each treatment group.
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discussed in this publication into the National 
Center for Biotechnology Information’s 
Gene Expression Omnibus data repository 
(http://www.ncbi.nlm.nih.gov/geo/, series 
GSE25095) and the National Institute of 
Environmental Health Sciences Chemical 
Effects in Biological Systems database (http://
cebs.niehs.nih.gov/, accession no. 005-00003-
0070-000-5). Details of the processes used to 
identify genes with altered transcript levels as 
a function of exposure, strain, and/or time are 
in the Supplemental Material (doi:10.1289/
ehp.1002182). After consolidating probe sets, 
we loaded the resulting list of 165 genes and 
annotation into IPA (version 7.4, April 2009) 
to identify unique gene expression pathways 
that reflected an interaction between strain 
and treatment effect.
Statistics. We expressed all data as group 
means ± SE. We log-transformed PMN data 
to ensure normal data distribution and equal 
variance. We assessed differences in effects 
of O3 and IL-10 on response phenotypes 
by two-factor ANOVA. The factors were 
exposure (air or O3) and genotype (Il10+/+ 
or Il10–/–). Dependent variables were BALF 
protein concentration, BALF cells, mRNA 
expression, and protein levels. We used the 
Student Newman–Keuls post hoc test to 
compare group means. We performed all sta-
tistical analyses using the SigmaStat statis-
tics package (version 3; Systat Software, Inc., 
Point Richmond, CA). We accepted statisti-
cal significance at p < 0.05. Sample sizes are 
included in the figure captions.
Results
Lung inflammatory responses. O3-induced 
increases in total numbers of BALF cells were 
significantly greater in Il10–/– compared with 
Il10+/+ mice [see Supplemental Material, 
Table 1 (doi:10.1289/ehp.1002182)] and 
largely attributable to differences in total 
numbers of PMNs. Compared with Il10+/+ 
mice, the numbers of PMNs were signifi-
cantly greater (~3-fold) in Il10–/– mice at each 
O3 exposure time point (Figure 1A). Total 
BALF protein concentrations also increased 
significantly in both genotypes after O3, but 
we found no significant differences between 
the two genotypes (p = 0.055; Figure 1B).
Histopathological analysis of lung injury. 
Consistent with BALF phenotypes, we found 
greater O3-induced inflammation in perivas-
cular, peribronchiolar, and terminal bronchial 
regions in hemotoxylin and eosin (H&E)-
stained lung tissue sections from Il10–/– mice 
compared with Il10+/+ mice (Figure 1C). 
Further, the density of Ki67-positive cells at 
distal perivascular-peribronchiolar areas and 
centriacinar regions was more prominent in 
Il10–/– than in Il10+/+ mice exposed to O3, 
indicating enhanced cellular proliferation 
(Figure 1D).
Inflammatory mediator production. We 
did not detect Il10 mRNA expression in Il10–/– 
mouse lung homogenates after air or O3 expo-
sure (data not shown). However, Il10 mRNA 
was significantly elevated relative to air-exposed 
controls after 24-hr O3 (4.4-fold; p < 0.05) but 
was not significantly different between air- and 
O3-exposed Il10+/+ mice after 48- and 72-hr 
exposures (data not shown). Relative to respec-
tive air controls, O3 significantly increased 
mean BALF concentration of the PMN 
chemoattractant MIP-2 in both genotypes 
and was significantly higher in Il10–/– com-
pared with Il10+/+ mice at 24 hr (Figure 2A). 
However, these genotype-  dependent differ-
ences were not evident at 48- and 72-hr O3. 
TNF-α and iNOS mRNA expression levels 
were significantly increased in both strains dur-
ing O3, but we found no significant genotypic 
differences (data not shown).
SOCS3 expression. Because SOCS3 
has been proposed as a mechanism of 
IL-10–mediated protection against inflam-
matory processes in other models of lung dis-
ease (Gao and Ward 2007), we asked whether 
SOCS3 was differentially expressed in Il10–/– 
and Il10+/+ mice. Relative to air controls, Socs3 
mRNA expression increased significantly in 
Il10+/+ mice after 24-, 48-, and 72-hr O3 
(Figure 2B); Socs3 expression in Il10–/– mice 
was increased significantly only after 72-hr O3.
CD86 production. Compared with Il10+/+ 
mice, we found significantly higher levels of 
lung CD86 proteins in Il10–/– mice after air and 
O3 (Figure 2C). However, O3 did not increase 
CD86 in either genotype, and we found no 
interaction between genotype and exposure.
Nuclear NF-κB activity and STAT3 acti-
vation. To determine whether the protec-
tive effect of IL-10 may be mediated in part 
by differential NF-κB activity, we evaluated 
nuclear DNA binding activity of total NF-κB 
and specific p50, a subunit of NF-κB and 
p65 κB activity in Il10+/+ and Il10–/– mice. 
Interestingly, baseline binding activity of 
total NF-κB and specific p50 κB was slightly 
greater in Il10–/– mice than in Il10+/+ mice 
(Figure 3A). O3 effects on activation of total 
NF-κB and specific p50 κB binding activity 
were more marked in Il10–/– mice than in 
Il10+/+ mice (Figure 3A). Specific p65 subunit 
NF-κB activity was significantly increased 
only in Il10–/– mice after O3 (Figure 3A). The 
ratio of phosphorylated STAT3 (p-STAT3) 
to STAT3 protein in the lung increased sig-
nificantly after O3 compared with air con-
trols in both genotypes, signifying an increase 
in activated STAT3 protein in response to 
O3 (Figure 3B). However, we found no 
differences in O3-induced increases in the 
p-STAT3:STAT3 ratio between Il10–/– and 
Il10+/+ mice.
O3-induced gene expression profiles are 
altered in Il10+/+ compared with Il10–/– mice. 
We first used unsupervised analyses of gene 
Figure 2. (A) MIP-2 protein levels in BALF recovered from Il10+/+ and Il10–/– mice exposed to air and 0.3 ppm O3 (means ± SE; n = 4 per group). *p < 0.05, air versus 
O3; **p < 0.05, Il10+/+ versus Il10–/–. (B) Socs3 mRNA expression in Il10+/+ and Il10–/– mice in response to air or 0.3 ppm O3. We determined the ratio of Socs3 to 
18S RNA from whole-lung homogenates from PCR (means ± SE; n = 3 per group). *p < 0.05, air versus 0.3 ppm O3. (C) Lung CD86 protein expression in Il10+/+ and 
Il10–/– mice exposed to air and 0.3 ppm O3 (means ± SE; n = 3–5 per group). We detected CD86 expression from whole-lung homogenates by Western blot analysis 
and reprobed blots with actin for normalization. +p < 0.05.
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expression profiles in Il10–/– and Il10+/+ mice 
to provide additional insight into the means 
through which IL-10 protects the lung against 
O3-induced inflammation. Using k-means 
clustering analysis, we identified differen-
tial gene expression profile patterns between 
Il10+/+ and Il10–/– mice that suggested geno-
type-independent and genotype-specific O3 
effects [for gene expression clusters and gene 
lists, see Supplemental Material (doi:10.1289/
ehp.1002182)]. IPA revealed distinct gene 
expression pathways for specific O3-induced 
changes that displayed similar kinetics between 
Il10+/+ and Il10–/– mice [Figure 4, red shapes; 
see also Supplemental Material, Table 2, 
Figure 5A (doi:10.1289/ehp.1002182)]. For 
example, Gale (galatose-4-epimerase, UDP), 
Hat1 (histone acetyl transferase 1), and Ccr1 
[chemokine (C-C motif) receptor-1] expres-
sion was altered after O3 (Figure 4A, red 
shapes). In addition, we observed O3-induced 
gene expression profile differences in Il33 
in Il10–/– and Il10+/+ mice (Figure 4B, red 
shapes), Socs3, and Il1 (Figure 4C, red shapes). 
This is consistent with Figure 2B that shows 
parallel increases in Socs3 transcript level in 
both strains, although statistical testing 
revealed a significant increase in Il10+/+ mice 
earlier than in the Il10–/– mice. These genes 
are associated with stress and inflammatory 
pathways [see Supplemental Material, Table 3 
(doi:10.1289/ehp.1002182)]. Moreover, 
we found O3-induced gene expression pat-
terns that were altered temporally in Il10–/– 
compared with Il10+/+ mice [Figure 4, green 
shapes; see also Supplemental Material, Figure 
5D, Table 2 (doi:10.1289/ehp.1002182)].
We also applied supervised analysis using 
GeneSpring to identify genes that varied sta-
tistically significantly between Il10+/+ and 
Il10–/– mice during 24- to 72-hr O3 [see 
Supplemental Material, Figure 6, Table 4 
(doi:10.1289/ehp.1002182)]. Genes > 2-fold 
higher in Il10–/– mice than in Il10+/+ mice 
included those encoding CTSE, WDFY1 
(WD repeat and FYVE domain containing 
1), IL-1β, SAA3, nicotinamide nucleotide 
transhydrogenase (NNT), and peptidylglycine 
α-amidating monooxygenase (PAM). Many 
of these genes were also elucidated by unsu-
pervised analysis [see Supplemental Material, 
Table 4 (doi:10.1289/ehp.1002182)]. We 
validated a subset of the genes (n = 4) listed 
in the Supplemental Material, Table 4 
(doi:10.1289/ehp.1002182), by measuring 
mRNA expression in lung homogenates from 
air- and O3-exposed Il10–/– and Il10+/+ mice. 
We found that mRNA expression of Ctse (24 
hr), Wdfy1 (24, 48 hr), Saa3 (48 hr), and 
S100a14 (S100 calcium binding protein A14; 
24, 48, and 72 hr) was significantly (p < 0.05) 
greater in Il10–/– than in Il10+/+ lung homo-
genates [see Supplemental Material, Figure 7 
(doi:10.1289/ehp.1002182)].
Discussion
We investigated the mechanisms of IL-10–
mediated reductions in O3-induced airway 
neutrophilia in mice. Targeted deletion of 
Il10 significantly enhanced O3-induced pul-
monary cellular inflammation, as indicated by 
significant differences in numbers of infiltrat-
ing neutrophils and enhanced cellular prolif-
eration in centriacinar regions compared with 
Il10+/+ controls. Nuclear activity of NF-κB 
and expression of CD86 proteins were also 
greater in lungs of Il10–/– mice. Furthermore, 
MIP-2 protein was significantly elevated in 
response to 24-hr O3 and was exacerbated in 
Il10–/– compared with Il10+/+ mice. Results 
support a role for IL-10 in protection against 
O3-induced inflammation associated with 
diminished NF-κB activity and MIP-2 pro-
duction. Nonbiased (visual, unsupervised) 
and supervised (ANOVA) gene array analysis 
identified novel cellular targets that may con-
tribute to the protective mechanism of IL-10 
in O3-induced inflammation.
O3-induced increases in BALF neutrophils 
and lung cell proliferation were significantly 
enhanced in Il10–/– mice relative to Il10+/+ 
wild-type controls, but the lung permeability 
response to O3 was not significantly differ-
ent between the two genotypes. Interestingly, 
Reinhart et al. (1999) found that intra-
tracheal instillation of recombinant IL-10 
into Sprague-Dawley rats significantly attenu-
ated by 25% protein permeability responses 
induced by acute O3 exposure (0.8 ppm, 3 
hr) compared with controls. An explanation 
for the disparate observations is not entirely 
clear, but the role of IL-10 in the hyper-
permeability response may depend on the 
concentration and duration of exposure to O3 
(0.8 ppm for 3 hr compared with 0.3 ppm for 
24, 48, or 72 hr) or may be species specific. 
Moreover, these results are consistent with 
previous studies suggesting that inflammatory 
and per  meability responses in this model are 
regulated through different mechanisms (e.g., 
Cho et al. 2007).
Upregulation of the PMN chemo-
attractant MIP-2 has been suggested to regu-
late initial neutrophilic infiltration in response 
to O3. O3-induced increases in MIP-2 were 
potentiated in the absence of Il10 at 24 hr 
before the peak PMN influx and therefore 
may be a mechanism through which IL-10 
protects against O3-induced inflammation 
and cell proliferation. Similarly, neutralization 
Figure 3. (A) EMSA to determine DNA binding activity of total NF-κB (top left) and specific p50 κB (top right) after 0.3 ppm O3 in Il10+/+ and Il10–/– mice. Each lane 
represents nuclear protein pooled from three representative animals of each treatment group and was repeated three times. SB, shifted band; SSB, supershifted 
band; FP, free probe. Quantified p65 κB determined by ELISA is presented below (means ± SE; n = 3 per group). *p < 0.05, air versus 0.3 ppm O3; **p < 0.05, Il10+/+ 
versus Il10–/–. (B) Phosphorylated STAT3 (p-STAT3) in Il10+/+ and Il10–/– mice in response to air or 0.3 ppm O3. We determined the ratio of p-STAT3 to total STAT3 
from whole-lung homogenates by Western blot analysis (means ± SE; n = 3 per group). *p < 0.05, air versus 0.3 ppm O3.
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of IL-10 prior to LPS administration can 
attenuate production of MIP-2 and associ-
ated neutrophilia (Standiford et al. 1995). We 
observed no significantly different O3-induced 
changes in TNF-α and iNOS between Il10–/– 
and Il10+/+ mice, despite genotype-specific 
differences in NF-κB after O3. These results 
suggest that O3-induced increases in TNF-α 
and iNOS, which are thought to be NF-κB 
dependent (e.g., Cho et al. 2007), are not 
modulated by IL-10. These results are incon-
sistent with those of Lang et al. (2002) and 
Standiford et al. (1995), who found that 
TNF-α production is IL-10 dependent in 
responses to endotoxin. Collectively, these 
studies may suggest important differences in 
pulmonary cellular responses to endotoxin 
and O3 and warrant further investigation.
We also found that lung CD86 protein 
levels were enhanced in Il10–/– compared with 
Il10+/+ mice, independent of O3 exposure. 
Soltys et al. (2002) showed that CD86 in alve-
olar macrophages was significantly enhanced in 
Il10–/– mice at baseline and suggested that low 
levels of alveolar macrophage costimulatory 
molecule expression are maintained at least 
in part by endogenous IL-10 activity. Koike 
et al. (2001) found that approximately 8% 
of alveolar macrophages obtained from rats 
exposed to 1 ppm O3 for 3 days were CD86 
positive and suggested that small increases in 
costimulatory activity may be sufficient to reg-
ulate O3-induced immune responses. Our data 
similarly indicate that Il10 deficiency permits 
endogenous CD86 expression, which could 
explain why we did not detect subtle increases 
in CD86 in Il10–/– mice after O3 exposure.
To investigate the potential signaling path-
way through which IL-10 protects against 
O3-induced inflammation, we evaluated 
NF-κB activation in Il10+/+ and Il10–/– mice. 
NF-κB is a nuclear protein that regulates 
transcription of many gene products that acti-
vate major pulmonary inflammatory path-
ways, including responses to O3 (Cho et al. 
2007). IL-10 inhibits NF-κB (Saadane et al. 
2005; Spight et al. 2005). We found that 
O3-induced p50 levels and p65 κB binding 
activity were significantly greater in Il10–/– 
than in Il10+/+ mice. The mechanism through 
which IL-10 inhibits NF-κB may occur indi-
rectly, such as through inhibition of inhibitory 
kappa kinase, as demonstrated in response to 
LPS (Saadane et al. 2005; Spight et al. 2005).
STAT3 was associated with IL-10–mediated 
inhibition of alveolar macrophage activation 
by LPS (Berlato et al. 2002). Stat3 has also 
been shown to mediate O3-induced inflam-
mation (Laskin et al. 2002) and pulmonary 
inflammation and hyperresponsiveness associ-
ated with asthmatic responses (Corry 2002). 
Interestingly, we found no significant genotype-
specific differences in the p-STAT3:STAT3 
Figure 4. IPA illustrates the three most highly associated networks (A–C) of IL-10–dependent genes in response to O3. Red symbols, genes whose profiles were 
derived from Supplemental Material Figure 5A [see Supplemental Material, Figure 5, Table 2 (doi:10.1289/ehp.1002182)]; yellow symbols, genes with profiles that 
followed the pattern illustrated in Supplemental Material Figure 5B (see Supplemental Material, Figure 5, Table 2); green symbols, genes with profiles that differ 
between Il10+/+ and Il10–/– mice [see Supplemental Material, Figure 5D, Table 2 (doi:10.1289/ehp.1002182)]. Gene abbreviations are identified in Supplemental 
Material, Table 2. GPCR, G-protein–coupled receptor.
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ratio (Figure 3B). Similarly, gene array analysis 
did not detect an interaction among O3 expo-
sure, Il10 deficiency, and Stat3 gene expression 
at these time points. These results suggest that 
O3-induced STAT3 activation occurs in an 
IL-10–independent manner.
To further elucidate the potential mecha-
nism through which IL-10 protects the lung 
against O3-induced inflammation, we used 
k-means clustering and Ingenuity analyses 
of microarray expression data. We identified 
three distinct clusters of molecules, represent-
ing three pathways and numerous gene tar-
gets. Several genes identified in this analysis 
(e.g., Il6, Il1ra, Il1) contribute to O3-induced 
pulmonary inflammation in mice (Figure 4).
Other identified genes represent novel 
targets for O3-induced inflammation. For 
example, both gene expression analyses iden-
tified Ctse as differentially expressed between 
genotypes after exposure to O3. Ctse is a an 
intracellular aspartic protease that is found 
in immune system cells such as dendritic 
cells and macrophages and has been impli-
cated in major histocompatibility complex 
(MHC) class II pathway antigen processing 
(e.g., Zaidi and Kalbacher 2008). Although 
Ctse has not been associated with O3-induced 
inflammation, MHC class II molecules 
have been implicated recently in the PMN 
response to O3 exposure in the mouse (Bauer 
et al. 2009), and it is plausible that CTSE 
could also be involved in this pathway. SAA 
and S100A14 have been implicated in inflam-
matory processes (e.g., Han et al. 2007) or 
inflammation-related diseases (Chen et al. 
2009) and thus provide a rationale for a role 
in O3-induced inflammation.
Our gene array analysis identified Socs3 as 
being induced in response to O3, compared 
with air controls. RT-PCR analyses confirmed 
O3-induced upregulation of Socs3 and identi-
fied a small but statistically significant differ-
ence in expression kinetics between Il10+/+ 
and Il10–/– mice. Members of the SOCS 
signaling family, including SOCS3, regulate 
activation and function of STAT3 (Gao and 
Ward 2007). Emerging data on activation and 
function of STAT3 and SOCS3 in the lung 
during acute inflammation suggest that these 
molecules may regulate pulmonary inflam-
mation (Gao and Ward 2007), and they have 
specifically been implicated in allergic air-
way inflammation (Paul et al. 2009). Given 
that SOCS3 is a proximal mediator associated 
with IL-10 ligand binding, the role of SOCS3 
in O3-induced inflammation necessitates fur-
ther investigation to determine its specific 
contribution to the adaptive/innate immune 
response.
The array analysis implicated a number of 
novel genes for response to O3 in Il10+/+ and 
Il10–/– mice, including Il33 and Hat1. IL-33 
is a member of the IL-1 superfamily and is 
expressed on epithelial cells. This cytokine has 
been identified in joints of arthritis patients 
(Palmer et al. 2009) and is implicated in devel-
opment and regulation of type 2 T-helper 
cell–dependent immune responses in sites 
of mucosal immunity, which may suggest a 
link between innate and adaptive immune 
responses after O3 exposure (Saenz et al. 
2008). HAT1, an acetylation enzyme, controls 
access to DNA transcription by controlling 
histone protein activation during chromatin 
assembly (Parthun 2007). Although HAT1 
expression has been linked to inflammatory 
mediators such as interferon-γ and TNF-α 
(Keslacy et al. 2007), the specific role of 
HAT1 in response to O3 remains unclear.
Conclusion
This study supports the hypothesis that IL-10 
protects against O3-induced lung inflamma-
tion and identified several potential mech-
anisms involved in this response. IL-10 
deficiency enhanced O3-induced neutrophilic 
inflammation and injury at the centriacinar 
region of the lung. Results also suggest that 
in response to O3 the effect of IL-10 may be 
mediated, in part, via modulation of NF-κB, 
MIP-2, and CD86. Gene array analysis identi-
fied three IL-10–mediated expression pathways 
with genes known previously to be affected by 
O3 and novel genes that may contribute sig-
nificantly to the pathogenesis of O3-induced 
pulmonary inflammation. The present investi-
gation identified novel molecular mechanisms 
of pulmonary O3 toxicity, which may provide 
possible therapeutic targets for attenuating the 
effects of O3 in susceptible individuals.
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